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a b s t r a c t
BK Polyomavirus (BKPyV) is a ubiquitous nonenveloped human virus that can cause severe disease in
immunocompromised populations. After internalization into renal proximal tubule epithelial cells,
BKPyV trafﬁcs through the ER and enters the cytosol. However, it is unclear how the virus enters the
nucleus. In this study, we elucidate a role for the nuclear localization signal located on the minor capsid
proteins VP2 and VP3 during infection. Site-directed mutagenesis of a single lysine in the basic region of
the C-terminus of the minor capsid proteins abrogated their nuclear localization, and the analogous
genomic mutation reduced infectivity. Additionally, through use of the inhibitor ivermectin and
knockdown of importin β1, we found that the importin α/β pathway is involved during infection.
Overall these data are the ﬁrst to show the signiﬁcance of the NLS of the BKPyV minor capsid proteins
during infection in a natural host cell.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Polyomaviruses are ubiquitous in the human population. The
polyomavirus BKPyV usually infects in early childhood, establish-
ing a subclinical persistent infection in the host. However, reacti-
vation in immunosuppressed individuals, particularly bone
marrow and kidney transplant patients, can lead to severe disease
(Jiang et al., 2009a). Currently there are no BKPyV-speciﬁc anti-
virals and the only treatment is palliative therapy or reduction of
immunosuppression, with the latter treatment leaving renal
transplant patients open to organ rejection. In addition to the
intrinsic value of uncovering aspects of viral and host biology,
understanding the life cycle of the virus within the host cell will
provide much needed information for future development of
targeted therapies to lessen BKPyV reactivation and disease.
The BKPyV particle is nonenveloped and consists of three
structural proteins, including the major capsid protein VP1 and
minor capsid proteins VP2 and VP3. The structural proteins
encapsidate the 5.2 Kb circular double stranded DNA genome,
which takes the form of a minichromosome associated with
cellular histones (Meneguzzi et al., 1978). The outer layer of the
viral particle is made up of 72 VP1 pentamers stabilized by
intermolecular disulﬁde bonds (Nilsson et al., 2005). Associated
with each pentamer is one molecule of either VP2 or VP3, which
are not exposed to the surface of the particle until disassembly
begins within the endoplasmic reticulum (ER) of the host cell
(Bennett et al., 2013). VP2 and VP3 are expressed from the same
reading frame and share an identical C-terminus, but VP2 contains
a unique N-terminal sequence that can be myristoylated
(Krauzewicz et al., 1990). Our lab has previously shown in renal
proximal tubule epithelial (RPTE) cells that BKPyV reaches the ER
at 8–10 hpi (Jiang et al., 2009b), then trafﬁcs through the cytosol at
16 hpi (Bennett et al., 2013), followed by nuclear entry and early
gene expression beginning at 24 hpi (Low et al., 2004). Data
suggest that BKPyV and other polyomaviruses exit the ER and
enter the cytosol using components of the ER-associated degrada-
tion pathway (Bennett et al., 2013; Geiger et al., 2011; Goodwin
et al., 2011; Jiang et al., 2009b; Walczak et al., 2014).
Previous studies have provided conﬂicting evidence for the
nuclear entry mechanism of polyomaviruses. The virus could enter
the nucleus through the nuclear pore complex, since partial
uncoating would make the virus particle small enough for active
transport through the pore (Pante and Kann, 2002). Studies from
Nakanishi et al. have shown an interaction between importins α
and β and the SV40 chromosome in the cytosol, suggesting the use
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of the canonical nuclear import pathway during SV40 nuclear
entry (Nakanishi et al., 2007, 2002). Importins α and β are adapter
proteins that recognize and bind a nuclear transport signal made
up of basic amino acids called a nuclear localization signal (NLS).
Certain basic amino acids in the C-terminus of SV40 VP2 and VP3
(VP2/3) were found to be necessary for the interaction with the
importins, suggesting that entry of SV40 through the nuclear pore
complex is mediated by interactions between an NLS on the minor
capsid proteins VP2/3 and the canonical nuclear import machinery
(Nakanishi et al., 2007; Nakanishi et al., 2002). However, studies
by Butin-Israeli et al. provided evidence that SV40 infection leads
to breakdown of the nuclear lamina and disruption of the nuclear
envelope, allowing the virus to pass from the ER lumen directly
into the nucleus (Butin-Israeli et al., 2011).
In this study we have evaluated the role of the nuclear localiza-
tion signal of the minor capsid proteins VP2 and VP3 during entry of
BKPyV in RPTE cells. We found that a speciﬁc lysine in VP2 and VP3
was important for localization to the nucleus, and that mutation of
this lysine attenuated infection and hindered viral entry at a point
after ER trafﬁcking. These ﬁndings further describe the trafﬁcking
route of BKPyV, and suggest a model where polyomavirus can enter
the nucleus from the cytosol through the nuclear pore, using the
minor capsid protein NLS as the import signal.
Results
Lysine 319 on VP2 and lysine 200 on VP3 are critical for nuclear
localization of the minor capsid proteins
Because BKPyV VP2 and VP3 share homology with SV40,
especially in the basic C-terminal amino acids important for
nuclear localization of the SV40 proteins (Gharakhanian and
Kasamatsu, 1990; Gharakhanian et al., 1987) (Fig. 1A), we hypothe-
sized that VP2 and VP3 of BKPyV would also possess a nuclear
localization signal that mapped to these residues. To test this, we
expressed VP2 or VP3 alone in RPTE cells by transfection of
expression plasmids. In RPTE cells, both VP2 and VP3 showed
nuclear localization (Fig. 1B). We next determined the amino acids
necessary to confer this nuclear localization. It has been previously
shown that lysine 202 on SV40 VP3 and the same amino acid at
residue 320 of VP2 was vital for nuclear localization of the SV40
minor capsid proteins (Gharakhanian and Kasamatsu, 1990).
Therefore, we targeted the homologous lysine in BKPyV, K319 of
VP2 and K200 of VP3, for mutagenesis (Fig. 1A, arrow). Site-
directed mutagenesis was used to convert the lysine to a threo-
nine, and the mutant constructs were transfected into RPTE cells
to test localization of the proteins. Indeed, the mutants VP2K319T
and VP3K200T no longer localized to the nucleus (Fig. 1C).
For SV40, co-expression of VP1 allows for nuclear import of
nuclear localization-defective minor capsid proteins (Ishii et al.,
1994; Kasamatsu and Nehorayan, 1979). To test whether this was
also the case for BKPyV, we co-transfected a VP1 expression vector
with each of the VP2K319T and VP3K200T expression vectors. The
presence of VP1 led to nuclear localization of both VP2K319T and
VP3K200T (Fig. 1D). This observation suggests that the nuclear
localization signal on VP1 enables import of VP1-VP2 or VP1-VP3
complexes. These results also suggest that assembly of capsids,
which takes place in the nucleus, should not be affected by the
presence of a mutation in the minor capsid protein NLS.
The VP2/3 NLS is important for entry in RPTE cells
To evaluate the role of the minor capsid protein NLS during
infection, a point mutation was created in the viral genome to
convert lysine 319 of VP2 and 200 of VP3 to a threonine as was
done in the expression plasmids. Mutant and wild type genomes
were transfected into RPTE cells to produce virus. Lysates from the
transfected cells were blind passaged to infect a new set of RPTE cells.
Those infected RPTE cells were then harvested after two weeks and
the quantity of viral genomes in the lysates was measured using
qPCR. This crude stock was then used to grow a large scale stock of
puriﬁed virus. Of note, similar numbers of viral genomes were
measured for both puriﬁed and mutant viruses. PCR and DNA
sequencing was performed to ensure that the mutation was still
present in the ﬁnal puriﬁed virus (data not shown). Additionally, we
wanted to conﬁrm that VP2 and VP3 were incorporated into virions,
even though our transfections showed that the NLS-mutant VP2/3
could still be imported into the nucleus by VP1. Equal genomes were
resolved by SDS-PAGE and the resulting western blot was probed for
VP2/3, showing the presence of VP2 and VP3 in both wild type and
mutant viruses (Fig. 2A). While the VP2:VP3 ratio appears slightly
different, this is normal variation that we detect even among
different batches of wild type virus (data not shown). To test
infectivity of the mutant compared to wild type, equal numbers of
genomes were used to infect RPTE cells. Whole cell lysates were
collected at 24 hpi, resolved by SDS-PAGE, and probed for the early
protein large T Antigen (TAg). Compared to wild type virus (Dun),
Dunlop containing the VP2/VP3 lysine mutation (DunM) expressed
less TAg (Fig. 2B), suggesting a possible defect in entry.
To assess whether early entry events prior to nuclear import
were disrupted by the introduction of the mutation, we evaluated
disassembly and ER trafﬁcking. The disulﬁde bonds between the
VP1 pentamers become reduced as the virus trafﬁcs through the
ER; this disassembly process can be detected beginning around
12 hpi, and corresponds with increasing quantities of VP1 mono-
mers and oligomers in lysates prepared under non-reducing
conditions (Jiang et al., 2009b). To compare mutant and wild type
virus, RPTE cells were infected and protein lysates were harvested
at 0 hpi and 24 hpi under alkylating conditions. The lysates were
analyzed by SDS-PAGE under non-reducing conditions to detect
VP1 disassembly events that had occurred in the cell. At 0 hpi,
there was an absence of VP1 that entered the gel because the virus
particles were still fully assembled (Fig. 2C). Similar levels of VP1
disassembly intermediates were seen for both the wild type and
mutant virus at 24 hpi (Fig. 2C), suggesting that the mutant is able
to disassemble in the ER in a similar manner to wild type virus. As
another way of testing trafﬁcking of the mutant virus through the
ER, the exposure of the minor capsid proteins VP2 and VP3 was
assessed by immunoﬂuorescent staining. VP2 and VP3 become
accessible to antibody recognition as the virus particle becomes
partially disassembled in the ER, and thus immunoﬂuorescent
detection of the minor capsid proteins can be used as a readout for
disassembly (Norkin et al., 2002). For both mutant and wild type
BKPyV, staining for VP2/3 showed similar levels of puncta
throughout the cells (Fig. 2D). In cells treated with brefeldin A
(BFA), which inhibits trafﬁcking to the ER, no puncta were seen,
indicating the speciﬁcity of the assay. Together these data show
that disassembly and ER trafﬁcking still occurred during entry of
the mutant virus. Therefore, the defect leading to reduced TAg
expression in mutant virus infected cells is likely occurring at a
step between initial disassembly and nuclear entry.
Importin β-mediated nuclear import Is involved during infection
Since a classical NLS usually leads to nuclear import through
interaction with the transporter proteins importin α/β, we ﬁrst
evaluated the role of this pathway during infection through the use
of the inhibitor ivermectin, which speciﬁcally inhibits the importin
α/β nuclear import pathway without affecting other nuclear import
pathways (Wagstaff et al., 2012). RPTE cells were infected with wild
type BKPyV and treated with 10 mM ivermectin. Early gene expression
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of wild type BKPyV was evaluated by measuring TAg protein by
western blot and mRNA levels by RT-qPCR. TAg protein levels were
much lower in the treated lysates compared to those treated with the
vehicle butanol (Fig. 3A). Since the TAg protein itself normally
undergoes importin α/β-mediated nuclear import, TAg mRNA levels
were also measured to verify that the inhibitor was not simply
causing instability of the TAg protein by preventing its nuclear
localization. Quantitative RT-PCR demonstrated that TAg mRNA levels
were also decreased in the inhibitor-treated samples (Fig. 3B), sug-
gesting that the decrease in TAg protein was due to less viral gene
expression from inhibition of BKPyV entry into the nucleus. Interest-
ingly, the mutant virus was also sensitive to ivermectin treatment, as
there was a decrease in TAg mRNA expression from the mutant,
suggesting that the mutant virus retains the ability to use the nuclear
import pathway, albeit at a reduced level.
To further address a potential role for an importin-mediated
nuclear entry pathway in BKPyV infection, we knocked down
importin β1 protein levels through siRNA silencing. One day after
siRNA transfection, RPTE cells were infected with wild type BKPyV,
and protein or RNA was harvested at 24 hpi. Western blotting for
importin β1 protein showed an approximately 50% knockdown
(Fig. 3C, middle row). TAg levels measured by western blotting
were decreased in the knockdown samples compared to those
treated with a non-targeting siRNA, and TAg mRNA was also
decreased (Fig. 3D). These data provide additional support for
the role of the importin α/β canonical nuclear import pathway.
Discussion
The cellular entry pathway of polyomaviruses is only partially
understood, and many details remain to be elucidated. Previous
studies have provided evidence that after BKPyV or SV40 is
internalized, it travels through endocytosis to the ER, where
disassembly begins (Engel et al., 2011; Goodwin et al., 2011;
Jiang et al., 2009b; Schelhaas et al., 2007). After ER trafﬁcking,
the virus must enter the nucleus, and we and others have provided
data supporting a model in which polyomaviruses exit the ER into
the cytosol before nuclear entry, using the host pathway of ER-
associated degradation (ERAD) (Bennett et al., 2013; Geiger et al.,
2011; Goodwin et al., 2011; Jiang et al., 2009b; Walczak et al.,
2014). However, the mechanism of polyomavirus nuclear entry,
Fig. 1. Subcellular localization of NLS mutant VP2 and VP3 proteins. (A) VP3 Lysine 200 is conserved in a number of polyomavirus species. (B) Wild type VP2 and VP3
expression plasmids were transfected in RPTE cells, ﬁxed at 24 h, and stained with anti-VP2/3 (red). Nuclei were stained with DAPI (blue). Both VP2 and VP3 are nuclear, as
demonstrated by co-staining (bright purple) with DAPI. (C) RPTE cells were transfected with mutant VP3 (VP3K200R) or VP2 (VP2K319R) in the same manner. (D) RPTE cells
were co-transfected with VP1 and either VP2 or VP3, and stained for VP2/3, VP1, and DAPI.
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and speciﬁcally BKPyV nuclear entry, has so far remained ill-
deﬁned. In this report, we have provided evidence that an NLS on
the minor capsid proteins of BKPyV plays a role during entry,
suggesting that after the virus particle exits the ER, the minor
capsid proteins facilitate the process of nuclear import.
Previously, both of the minor capsid proteins of SV40 were
shown to localize to the nucleus, and the necessary amino acid
sequences were identiﬁed to include a QPNKKRR sequence
(Nakanishi et al., 2002). BKPyV capsid proteins have extensive
homology with SV40 proteins, but the localization properties of
BKPyV VP2 and VP3 have not been assessed previously, particu-
larly in the context of infection and in a natural host cell such as
RPTE cells. Here we have demonstrated nuclear localization of
both BKPyV VP2 and VP3 during expression in RPTE cells and
identiﬁed a lysine in the basic C-terminal sequence that was
important for this localization. The requirement for this lysine
seems to be speciﬁc as a mutation to similarly charged arginine
also abrogated nuclear localization of VP2/3 (data not shown). Of
note, after transfection into RPTE cells of the VP2 and VP3
expression plasmids, VP2 and VP3-positive cell numbers were
relatively low, perhaps due to the lytic properties of the minor
capsid proteins (Daniels et al., 2006).
After we identiﬁed a C-terminal VP2/3 residue required for
nuclear localization, we created the corresponding mutation in the
genome, simultaneously mutating both VP2 and VP3. We con-
ﬁrmed incorporation of VP2 and VP3 into the DunM virus by
western blot. Because the presence of wild type VP1 enables
nuclear import of nuclear localization-deﬁcient VP2 or VP3
(Fig. 1B), we could not assess differences in wild type and mutant
VP2/3 localization after expression from the viral genome, since
VP1 is expressed concurrently with VP2 and VP3. However,
decreased TAg protein and mRNA levels from the mutant at 24 h
after infection with equal genomes implies a defect during viral
entry. Since VP2/3 exposure in the ER still occurred, and the capsid
became reduced to a similar extent as wild type, it is likely that the
mutation does not cause a defect in the early, pre-nuclear entry
trafﬁcking steps. Interestingly, we observed an increased amount
of VP1 disassembly products during entry of the DunM virus. This
could be due to an increased particle to infectious genome ratio, or
a non-productive pathway may be favored for a nuclear entry-
defective virus, leading to increased disassembly products.
The importance of an NLS implies the involvement of the
classical importin α/β1 import pathway during nuclear entry.
Indeed, knockdown of importin β1 and treatment with ivermectin
both inhibited infection, supporting a model where BKPyV co-opts
this endogenous nuclear entry mechanism using the NLS of the
minor capsid proteins. The nuclear import inhibitor ivermectin
speciﬁcally targets the importin α/β1-mediated import pathway
without affecting the other import pathways including importin
β–mediated and transportin-mediated import (Wagstaff et al.,
2012). The NLS is recognized ﬁrst by the adapter importin α, then
importin β1 interacts with the substrate-NLS-importin α complex
to allow transport through the nuclear pore (Yoneda et al., 1999).
The inhibitory effect of ivermectin on BKPyV infection further
supports the use of active transport through the nuclear pore
complex by polyomaviruses for gaining access to the nucleus.
Fig. 2. Mutation in VP2/3 NLS attenuates infectivity of BKPyV. (A) Equal genome numbers of wild type (Dun) and NLS mutant (DunM) viruses were separated by SDS-PAGE
and analyzed by Western blotting for the presence of VP2 and VP3. (B) RPTE cells were infected with Dun and DunM virus at an MOI of 104 genomes per cell for 24 h. Whole
cell lysates were resolved by SDS-PAGE and probed for TAg and β actin. Quantiﬁcation was performed using the Li-Cor Odyssey system, with mock and mutant TAg levels
normalized to Dun, set to a value of 1. Results represent at least three independent experiments. (C) RPTE cells were infected with equal genomes and harvested immediately
or 24 h after adsorption under alkylating conditions, then whole cell lysates were resolved under reducing or non-reducing conditions by SDS-PAGE and probed for VP1 and
GAPDH. (D) RPTE cells were infected with equal genomes and left untreated or treated with BFA as a control for non-speciﬁc staining, then ﬁxed at 24 hpi and stained with
anti-VP2/3 and DAPI.
S.M. Bennett et al. / Virology 474 (2015) 110–116 113
A number of observations point to an alternative nuclear entry
pathway existing along with import through the nuclear pore. The
BKPyV NLS mutation only led to attenuated infectivity, and both
ivermectin treatment and importin β1 knockdown led to about a 50%
decrease in early gene expression. One alternative way for a cytosolic
viral particle to enter the nucleus is during mitosis, when nuclear
envelope breakdown occurs (Butin-Israeli et al., 2011). Additionally, it
is possible that BKPyV can use an alternative NLS from the C-terminal
one identiﬁed here. VP1 contains an NLS (Ishii et al., 1996; Moreland
and Garcea, 1991), but this motif is thought to be buried within the
partially disassembled particle, such that entry would rely on the
minor capsid proteins. However, it is possible that this VP1 NLS is
available during entry in RPTE cells, or that another VP2 and/or VP3
NLS functions in the context of the virus structure that does not
function when the proteins are expressed individually. Since iver-
mectin treatment inhibited the mutant to a similar extent as the wild
type virus, this suggests that the mutant can somehow still use the
canonical import pathway, supporting the use of another viral NLS.
Recent data implicating a possible connection between the nuclear
import and ERAD machinery might provide insight into a model for
BKPyV nuclear entry in RPTE cells. Importin β1 has been shown to be
necessary for the retrotranslocation of certain ERAD substrates (Zhong
et al., 2011), making it reasonable to suspect that the nuclear import
pathway provides a way for the movement of the virus out of the ER
to be energetically favorable, as it crosses into the cytosol, interacts
with nuclear import machinery on the cytosolic side of the ER
membrane, and proceeds into the nucleus through the nuclear pore.
In summary, we have demonstrated that a basic lysine in the C-
terminus of the minor capsid proteins is required for nuclear
import of the individually expressed minor capsid proteins.
Additionally, we have shown the involvement of the importin β1
canonical import pathway during entry. Our data suggest a model
where partially disassembled BKPyV exits the ER into the cytosol,
where the exposed NLS of VP2/VP3 is used to bring the viral
genome into the nucleus via the nuclear pore complex; but
another route of entry into the nucleus may exist as well.
Materials and Methods
Cell culture
RPTE cells were grown in renal epithelial basal growth medium
(REGM) with SingleQuots Bulletkit from Lonza at 37 1C and 5% CO2
and passaged up to six times as previously described (Abend et al.,
2007).
Transfection
The VP2 and VP3 expression plasmids were obtained from
Addgene, Cambridge, MA (plasmid numbers 32109, 32110). The VP1
expression plasmid was obtained from Christopher Buck, NCI,
Bethesda, MD. RPTE cells in a 12-well were transfected using 3 ml
Mirus LT-1 transfection reagent, and 1 mg plasmid DNA following
manufacturer's instructions (or 0.5 mg of each plasmid for the co-
transfection). LT-1 was mixed with 100 ml Opti-mem and incubated
15min before adding the DNA and then 25min at room temperature.
Infections
Puriﬁed wild-type and mutant BKPyV (Dunlop genetic back-
ground) was propagated and puriﬁed as previously described
Fig. 3. The canonical nuclear import α/β1 pathway is important for infection. (A) RPTE cells were infected at an MOI of 104 genomes/cell and treated with ivermectin (þ I) or
butanol (untreated, UT). Whole cell lysates were harvested at 24 hpi and resolved by SDS-PAGE, then probed for TAg and β actin. (B) RPTE cells were infected with 104
genomes/cell of wild-type (Dun) or mutant (DunM) and treated with ivermectin (þ I) at 10 mM at the beginning of infection or left untreated. RNA was harvested at 24 hpi
and reverse-transcription (RT) was performed followed by qPCR to measure TAg cDNA relative to GAPDH. (C) RPTE cells were transfected with Importin β1 siRNA (Imp β) or
non-targeting siRNA (N.T.), and then infected 2 d after transfection with wild type virus. Whole cell lysates were harvested at 24 hpi, resolved by SDS-PAGE, and probed for
TAg, B actin, and importin β1. (D) Transfection and infection was performed as in C, and RNAwas harvested at 24 hpi. RT and qPCR was performed as before. Results represent
three independent experiments.
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(Abend et al., 2007). Titers were based on genomes/ml after virus
puriﬁcation, measured by qPCR as described below. RPTE cells
were infected at 70% conﬂuence with a multiplicity of infection of
104 genomes per cell. Cells were pre-chilled 15 min and inoculated
with virus for one hour at 4 1C, then washed once with cold media
before adding warm media and incubating at 37 1C until the
desired time post infection. Ivermectin (Sigma) was dissolved in
ethanol according to manufacturer's instructions and used at a
ﬁnal concentration of 10 mM.
Quantitative PCR (qPCR) titering of genomes
To calculate genomes, 5 ml of virus stock was treated with 2 ml
DNase for 1 h at 37 1C, then treated with 50 mg proteinase K for 1 h
at 37, followed by isolation of the viral genomes by the QIAquick
PCR puriﬁcation kit (Qiagen). Dilutions of the isolated DNA were
used for qPCR and ﬁnal concentrations were calculated from a
standard curvein genomes/ml. QPCR was performed using primers
5’ TGTGATTGGGATTCAGTGCT 3’ and 5’ AAGGAAAGGCTGGATTC
TGA 3’in the TAg open reading frame.
Preparation of cell lysates
Whole cell protein lysates were harvested in E1A buffer
(50 mM HEPES pH 7, 250 mM NaCl, 0.1% NP40, with protease
inhibitors 5 mg/ml PMSF, 5 mg/ml aprotinin, 50 mM NaF, 0.2 mM
Na-orthovanadate, and 5 mg/ml leupeptin added just before use).
For alkylating conditions, 20 mM N-ethyl maleimide (Sigma) was
added to the E1A buffer. Protein concentrations were determined
using a Bradford assay after clarifying the lysate.
Western Blots
Equal amounts of proteinwere resolved by SDS-PAGE on a 10% gel
(8% for TAg), under reducing or non-reducing conditions and
transferred overnight onto a nitrocellulose membrane at 60 V by
wet transfer. Membranes were blocked in 2% nonfat dry milk in PBS
containing 0.1% Tween 20 (PBS-T). Antibodies were used at the
following concentrations diluted in PBS-T: anti-TAg PAb416 1:3000,
anti-VP1 P5G6 1:10,000, anti-VP2/3 1:3000, anti-GFP 1:2000, anti-
β-Actin (Cell Signaling) 1:5000, HRP-conjugated anti-mouse and
anti-rabbit (GE) 1:5000. For western blots analyzed by the Odyssey
system, membranes were blocked in Odyssey blocking buffer
(LI-COR) and probed with the indicated primary antibodies or anti-
mouse or anti-rabbit secondary antibodies diluted in Odyssey block-
ing buffer with 0.1% Tween 20.
Immunoﬂuorescence microscopy
At 24 h post transfection, cells were ﬁxed with cold 95% EtOH/ 5%
acetic acid. Cells were blocked with 5% goat serum in PBS, and then
coverslips were co-stained for indirect immunoﬂuorescence with
1:500 dilution of rabbit anti-VP2/3 and/or 1:200 mouse anti-VP1 in
goat serum. Secondary antibodies Alexa Flours 594 goat anti-rabbit
IgG or Alexa Fluors 488 goat anti-mouse (Invitrogen) were used at a
1:200 dilution. Cells were imaged with an inverted ﬂuorescence
microscope.
Reverse transcription and qPCR
At 24 h post-infection, RNA was harvested in Trizol and isolated
using the Zymo Research Direct-zol RNA mini-prep kit. RNA (150 ng)
was treated with DNase I then reverse transcription was performed
on RNA using the Qiangen Omniscript RT kit. QPCR was performed
on cDNA using primers for TAg (same as above), or GAPDH 5’
GCCTCAAGATCATCAGCAAT 3’ and 5’ CTGTGGTCATGAGTCCTTCC 3’.
Fold change in expression was determined using the ΔΔCt method
(Schmittgen and Livak, 2008).
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